The influx of investment in Seattle labs has surprised many, and some who have never considered the asset class are finding value in growing this asset class’s presence. Madrona VC made its first investment, further solidifying the viability of Seattle as a research hub, but how can we curate biotech lab clusters with limited land availability?
Being nimble with existing space has captured a lot of attention. An opportunity has arisen where we previously saw vulnerability/losses in Class B/C office. Conversions can elevate aging, unappealing commercial environments to attract startups and lease at a Seattle lab premium. Especially since given the lack of land availability, Class A lab spaces mean something different for us all.
Questions we will consider:
Are there strategic advantages in conversions for today’s end users in the current development landscape?
How might we re-evaluate space and the priority for labs.
What characteristics are attractive today in commercial biotech environments?
What are the deciding factors for developers to make the jump tomorrow?
Bisnow has gathered a panel of experts to speak on Establishing the Foundation for Biotech Ecosystems.
Hilary Hehman, Vice President, Fred Hutch
Margaret McCormick, Executive Director & COO, Benaroya Research Institute
Eric Pope, Associate Principal, DCI Engineers
Jonathon Marioneaux, Program Manager, Life Sciences, Clark Construction
Join us June 2nd at the link below.